論文- 武田 一也 -
表示方法: 表示形式: 表示順:
件数:10件
[2018]
1.Severe hypoxia increases expression of ATM and DNA-PKcs and it increases their activities through Src and AMPK signaling pathways..[Biochemical and biophysical research communications,(2018)]Hashimoto T, Murata Y, Urushihara Y, Shiga S, Takeda K, Hosoi Y
10.1016/j.bbrc.2018.09.068
http://www.ncbi.nlm.nih.gov/pubmed/30224064
2.Impact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancer..[Esophagus : official journal of the Japan Esophageal Society,15(3),(2018),190-197]Takeda K, Umezawa R, Takahashi N, Matsushita H, Kozumi M, Ishikawa Y, Yamamoto T, Takeda K, Jingu K
10.1007/s10388-018-0612-1
http://www.ncbi.nlm.nih.gov/pubmed/29951984
3.Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis..[Technology in cancer research & treatment,17,(2018),1533033818794936-]Jingu K, Matsushita H, Yamamoto T, Umezawa R, Ishikawa Y, Takahashi N, Katagiri Y, Takeda K, Kadoya N
10.1177/1533033818794936
http://www.ncbi.nlm.nih.gov/pubmed/30145943
4.Knockdown of AMPKα decreases ATM expression and increases radiosensitivity under hypoxia and nutrient starvation in an SV40-transformed human fibroblast cell line, LM217..[Biochemical and biophysical research communications,495(4),(2018),2566-2572]Murata Y, Hashimoto T, Urushihara Y, Shiga S, Takeda K, Jingu K, Hosoi Y
10.1016/j.bbrc.2017.12.141
http://www.ncbi.nlm.nih.gov/pubmed/29284117
[2017]
5.Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy..[Journal of radiation research,58(6),(2017),862-869]Takeda K, Takanami K, Shirata Y, Yamamoto T, Takahashi N, Ito K, Takase K, Jingu K
10.1093/jrr/rrx050
http://www.ncbi.nlm.nih.gov/pubmed/29036692
6.Whole-body total lesion glycolysis is an independent predictor in patients with esophageal cancer treated with definitive chemoradiotherapy..[Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,(2017)]Takahashi N, Umezawa R, Takanami K, Yamamoto T, Ishikawa Y, Kozumi M, Takeda K, Kadoya N, Jingu K
10.1016/j.radonc.2017.10.019
http://www.ncbi.nlm.nih.gov/pubmed/29108779
[2016]
7.Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study..[Journal of radiation research,57(6),(2016),655-661]Takahashi N, Yamamoto T, Matsushita H, Sugawara T, Kubozono M, Umezawa R, Ishikawa Y, Kozumi M, Katagiri Y, Tasaka S, Takeda K, Takeda K, Dobashi S, Jingu K
10.1093/jrr/rrw048
http://www.ncbi.nlm.nih.gov/pubmed/27422935
8.Regulation of DM-20 mRNA expression and intracellular translocation of glutathione-S-transferase pi isoform during oligodendrocyte differentiation in the adult rat spinal cord..[Histochemistry and cell biology,146(1),(2016),45-57]Kitada M, Takeda K, Dezawa M
10.1007/s00418-016-1421-z
http://www.ncbi.nlm.nih.gov/pubmed/26921198
9.The expression of PLP/DM-20 mRNA is restricted to the oligodendrocyte-lineage cells in the adult rat spinal cord..[Histochemistry and cell biology,145(2),(2016),147-161]Takeda K, Dezawa M, Kitada M
10.1007/s00418-015-1384-5
http://www.ncbi.nlm.nih.gov/pubmed/26563642
10.Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma..[Internal medicine (Tokyo, Japan),55(22),(2016),3325-3330]Takeda K, Matsushita H, Kubozono M, Tanabe T, Ishikawa Y, Yamamoto T, Kozumi M, Takahashi N, Katagiri Y, Tasaka S, Fukui K, Takeda K, Fujishima F, Ichinose M, Jingu K
10.2169/internalmedicine.55.6990
http://www.ncbi.nlm.nih.gov/pubmed/27853077
Page: [1]
戻るこのページのトップへ
copyright(c)2005 Tohoku University